Mitoimmune Therapeutics
Seoul
About Mitoimmune Therapeutics
Mito Immune Therapeutics is a drug research and development biotech company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $38.8M
- Last round: Series Unknown (Sep 2023)
- Website: mitoimmune.com
- Phone: +82 02 6933 6726
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/mitoimmune-therapeutics-72067 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.